Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML

Approval Number

SIN17033P

Drug Name

TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML

Product Name

TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML

Approval Date

June 27, 2024

Registrant

ROCHE SINGAPORE PTE. LTD.

Regulatory Information

Registrant

ROCHE SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

L01FF05

Manufacturer Information

Pharmaceutical Manufacturer

ROCHE SINGAPORE PTE. LTD.

Manufacturers

Roche Diagnostics GmbH

Active Ingredients

Ingredient Name

ATEZOLIZUMAB

Strength

1875 mg/15ml

Drug MonographAtezolizumab

Documents

Package Inserts

Tecentriq PI.pdf

Approved: June 27, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy